These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 802872)

  • 1. Protein analyses in myelomatosis.
    Carter PM; Slater L; Lee J; Perry D; Hobbs JR
    J Clin Pathol Suppl (Assoc Clin Pathol); 1975; 6():45-53. PubMed ID: 802872
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelomatosis.
    Rowan RM
    Compr Ther; 1977 Feb; 3(2):37-49. PubMed ID: 837659
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Myeloma cells after treatment with alkylating agents.
    Baccarani M; Santucci A
    Blood; 1975 Oct; 46(4):650-1. PubMed ID: 1174699
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of plasma cell myeloma with cytotoxic agents.
    Bergsagel DE; Pruzanski W
    Arch Intern Med; 1975 Jan; 135(1):172-6. PubMed ID: 803363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple myeloma].
    Wasastjerna C
    Duodecim; 1974; 90(10):751-64. PubMed ID: 4605799
    [No Abstract]   [Full Text] [Related]  

  • 6. IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia.
    Chiu W; Pullon H; Woon ST; Oei P; The R; Ameratunga R
    Pathology; 2010 Jan; 42(1):82-4. PubMed ID: 20025486
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prognostic factors in multiple myeloma].
    Boccadoro M; Bianchi A; Dianzani U; Frieri R; Gallone G; Massaia M; Omede P; Palumbo A; Pileri A
    Haematologica; 1989 Oct; 74(5 Suppl):347-57. PubMed ID: 2512219
    [No Abstract]   [Full Text] [Related]  

  • 8. Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study.
    Bonnet J; Alexanian R; Salmon S; Bottomley R; Amare M; Haut A; Dixon D
    Cancer Treat Rep; 1982 Jun; 66(6):1267-71. PubMed ID: 7044534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of abnormal immunoglobulin with clinical features of myeloma.
    Arch Intern Med; 1975 Jan; 135(1):46-52. PubMed ID: 1111470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of alkylating cytostatics on the development of secondary malignant tumors].
    Galajda P; Donner L
    Vnitr Lek; 1984 Aug; 30(8):756-63. PubMed ID: 6506498
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined cytostatic therapy of plasmacytoma].
    Albert P; Zsuzsa M
    Orv Hetil; 1977 Jul; 118(31):1855-6. PubMed ID: 887257
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Variety in general practice.
    Jacobs P; Dubovsky D; King HS
    S Afr Med J; 1975 Apr; 49(16):650-1. PubMed ID: 49083
    [No Abstract]   [Full Text] [Related]  

  • 13. Myelomatosis terminating in acute myelogenic leukaemia.
    Jaeger S
    Scand J Haematol; 1978 May; 20(5):410-2. PubMed ID: 276046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow changes following chemotherapy for multiple myeloma--a clinicopathological study of biopsy cases.
    Kurihara K; Hill W; Burkhardt R; Kettner G; Hashimoto N
    Nihon Ketsueki Gakkai Zasshi; 1987 Jul; 50(4):876-89. PubMed ID: 3687331
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytostatic therapy of hemoblastosis].
    Ehrhart H
    Pharmakotherapia; 1964; 2(1):59-88. PubMed ID: 5337120
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic progress--review XII. Treatment of multiple myeloma.
    Oakley JE; Franklin IM
    J Clin Hosp Pharm; 1984 Mar; 9(1):15-20. PubMed ID: 6371060
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring myelomatosis.
    Hobbs JR
    Arch Intern Med; 1975 Jan; 135(1):125-30. PubMed ID: 1111461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA synthesis in multiple myeloma cells following cell cycle-nonspecific chemotherapy.
    Alberts DS; Golde DW
    Cancer Res; 1974 Nov; 34(11):2911-4. PubMed ID: 4424360
    [No Abstract]   [Full Text] [Related]  

  • 19. [Monoclonal proteins preceding clinical signs of myelomatosis].
    Stepień-Dobrowolska M; Glebowska H; Milewicz A
    Wiad Lek; 1975 Mar; 28(5):423-5. PubMed ID: 1119150
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Alkylating agents and myeloma cells.
    Pileri A; Conte PF; Hulin N
    Blood; 1976 Jun; 47(6):1056-7. PubMed ID: 1276469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.